ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
124.495,68
0,15%
S&P 500
5.304,72
0,70%
US Dollar vs BRL
5,1732
0,00%
Bitcoin
69.372,32
-0,03%
Brent Oil
82,935
0,11%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Neovasc Inc (NVCN)

  7. Neovasc Inc (NVCN) Notícias

NVCN

Neovasc (NVCN)

Neovasc Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVCN
DataHoraFonteTítuloCódigoCompanhia
03/08/202301:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:NVCNNeovasc Inc
24/04/202317:15Edgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities Under Section 12(b) (15f-12b)NASDAQ:NVCNNeovasc Inc
12/04/202314:11Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NVCNNeovasc Inc
11/04/202310:11Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:NVCNNeovasc Inc
11/04/202310:08Edgar (US Regulatory)Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 1933 (f-10pos)NASDAQ:NVCNNeovasc Inc
11/04/202310:07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:NVCNNeovasc Inc
11/04/202310:06Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:NVCNNeovasc Inc
11/04/202309:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:NVCNNeovasc Inc
11/04/202309:20GlobeNewswire Inc.Shockwave Medical Completes Acquisition of NeovascNASDAQ:NVCNNeovasc Inc
31/03/202317:11GlobeNewswire Inc.Neovasc Announces Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
06/03/202319:37GlobeNewswire Inc.Neovasc Shareholders Approve Acquisition by Shockwave MedicalNASDAQ:NVCNNeovasc Inc
01/02/202311:05GlobeNewswire Inc.Neovasc Announces German Reimbursement RenewalNASDAQ:NVCNNeovasc Inc
17/01/202310:00GlobeNewswire Inc.Shockwave Medical to Acquire NeovascNASDAQ:NVCNNeovasc Inc
17/01/202310:00GlobeNewswire Inc.Shockwave Medical Announces Agreement to Acquire NeovascNASDAQ:NVCNNeovasc Inc
28/11/202218:45GlobeNewswire Inc.Neovasc Announces Progress on COSIRA-II Clinical TrialNASDAQ:NVCNNeovasc Inc
18/11/202211:05GlobeNewswire Inc.Neovasc Comments on European Heart Journal PublicationNASDAQ:NVCNNeovasc Inc
15/11/202208:45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Neovasc (NVCN)NASDAQ:NVCNNeovasc Inc
10/11/202218:05GlobeNewswire Inc.Neovasc Announces Third Quarter Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
08/11/202211:05GlobeNewswire Inc.Neovasc Reducer Obtains U.S. Outpatient ReimbursementNASDAQ:NVCNNeovasc Inc
27/10/202210:00GlobeNewswire Inc.Neovasc to Report Third Quarter Financial Results on November 10, 2022NASDAQ:NVCNNeovasc Inc
20/09/202210:05GlobeNewswire Inc.Neovasc Provides Corporate Update Following Clinical Data ReleaseNASDAQ:NVCNNeovasc Inc
16/09/202210:00GlobeNewswire Inc.Neovasc to Participate in LSI Europe 2022 Emerging MedTech SummitNASDAQ:NVCNNeovasc Inc
15/09/202210:05GlobeNewswire Inc.Neovasc Comments on New ICD-10-CM Diagnosis Codes for Refractory AnginaNASDAQ:NVCNNeovasc Inc
08/09/202210:05GlobeNewswire Inc.Neovasc Announces Key Events at TCT 2022NASDAQ:NVCNNeovasc Inc
30/08/202210:05GlobeNewswire Inc.Neovasc to Participate in H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:NVCNNeovasc Inc
22/08/202207:20TipRanksAnalysts Offer Insights on Healthcare Companies: Freeline Therapeutics Holdings (FRLN), Cabaletta Bio (CABA) and Neovasc (NVCN)NASDAQ:NVCNNeovasc Inc
11/08/202217:05GlobeNewswire Inc.Neovasc Announces Second Quarter Financial Results and Provides Corporate UpdateNASDAQ:NVCNNeovasc Inc
28/07/202210:00GlobeNewswire Inc.Neovasc to Report Second Quarter Financial Results on August 11, 2022NASDAQ:NVCNNeovasc Inc
26/07/202210:05GlobeNewswire Inc.Neovasc Announces FDA Approval of Planned COSIRA II Sub-studies and Single Arm Registry to Allow Inclusion of Additional Specified Patient PopulationsNASDAQ:NVCNNeovasc Inc
05/07/202210:05GlobeNewswire Inc.Neovasc Announces Direct Sales Operations in United KingdomNASDAQ:NVCNNeovasc Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVCN

Seu Histórico Recente

BOV
GFSA3
GAFISA ON
BOV
AERI3
Aeris Industria E Comerc... ON
BOV
COGN3
COGNA ON
BOV
TECN3
TECHNOS ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados